Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Propofol for Continuous Sedation of Ventilated Patients in Intensive Care Unit

NCT00479661 is registered in ClinicalTrials.gov with Orion Corporation, Orion Pharma as lead sponsor.

NCT NCT00479661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00479661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Propofol for Continuous Sedation of Ventilated Patients in Intensive Care Unit
Lead sponsor
Orion Corporation, Orion Pharma
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
March 31, 2010
Enrollment
500 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

continuous sedation in initially sedated adults in icu